rosiglitazone has been researched along with deamino arginine vasopressin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bryer-Ash, M; Ghazeeri, G; Haas, D; Ke, RW; Kutteh, WH | 1 |
1 review(s) available for rosiglitazone and deamino arginine vasopressin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for rosiglitazone and deamino arginine vasopressin
| Article | Year |
|---|---|
Effect of rosiglitazone on spontaneous and clomiphene citrate-induced ovulation in women with polycystic ovary syndrome.
Topics: Adolescent; Adult; Blood Glucose; Clomiphene; Deamino Arginine Vasopressin; Dehydroepiandrosterone Sulfate; Double-Blind Method; Fasting; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Ovulation Induction; Placebos; Polycystic Ovary Syndrome; Pregnancy; Pregnancy Outcome; Rosiglitazone; Sex Hormone-Binding Globulin; Testosterone; Thiazoles; Thiazolidinediones | 2003 |